Pedra has developed the world's first real-time non-invasive blood perfusion monitor that will be used in hospitals during balloon angioplasty of lower limb vessels. Our technology will significantly reduce the 30% and 24% rates of 30-day repeat procedures and foot amputations respectively in the United States. The technology will also be used in diagnosis of critical diabetic foot ischemia. The market opportunity approximates US$2 billion.